Surface Plasmon Resonance (SPR) Sensor for Cancer Biomarker Detection

被引：116
作者：
Das, Sreyashi [1 ]
Devireddy, Ram [1 ]
Gartia, Manas Ranjan [1 ]
机构：
[1] Louisiana State Univ, Dept Mech & Ind Engn, Baton Rouge, LA 70803 USA
来源：
BIOSENSORS-BASEL | 2023年 / 13卷 / 03期
基金：
美国国家科学基金会;
关键词：
cancer; biomarker; biosensor; surface plasmon resonance; liquid biopsy; LABEL-FREE BIOSENSOR; SELF-ASSEMBLED MONOLAYERS; CARBOHYDRATE ANTIGEN 15-3; SENSITIVE DETECTION; GOLD NANOPARTICLES; GROWTH-FACTOR; EXTRACELLULAR VESICLES; QUANTUM DOTS; CARCINOEMBRYONIC ANTIGEN; DISTANCE DEPENDENCE;
D O I：
10.3390/bios13030396
中图分类号：
O65 [分析化学];
学科分类号：
070302 ; 081704 ;
摘要：
A biomarker is a physiological observable marker that acts as a stand-in and, in the best-case scenario, forecasts a clinically significant outcome. Diagnostic biomarkers are more convenient and cost-effective than directly measuring the ultimate clinical outcome. Cancer is among the most prominent global health problems and a major cause of morbidity and death globally. Therefore, cancer biomarker assays that are trustworthy, consistent, precise, and verified are desperately needed. Biomarker-based tumor detection holds a lot of promise for improving disease knowledge at the molecular scale and early detection and surveillance. In contrast to conventional approaches, surface plasmon resonance (SPR) allows for the quick and less invasive screening of a variety of circulating indicators, such as circulating tumor DNA (ctDNA), microRNA (miRNA), circulating tumor cells (CTCs), lipids, and proteins. With several advantages, the SPR technique is a particularly beneficial choice for the point-of-care identification of biomarkers. As a result, it enables the timely detection of tumor markers, which could be used to track cancer development and suppress the relapse of malignant tumors. This review emphasizes advancements in SPR biosensing technologies for cancer detection.
引用
收藏
页数：33
相关论文
共 208 条
[31]   Contribution of oncoproteomics to cancer biomarker discovery [J].
Cho, William C. S. .
MOLECULAR CANCER, 2007, 6 (1)
[32]   Additive assay of cancer marker CA 19-9 by SPR biosensor [J].
Chung, J. W. ;
Bernhardt, R. ;
Pyun, J. C. .
SENSORS AND ACTUATORS B-CHEMICAL, 2006, 118 (1-2) :28-32
[33]   Sequential analysis of multiple analytes using a surface plasmon resonance (SPR) biosensor [J].
Chung, J. W. ;
Bernhardt, R. ;
Pyun, J. C. .
JOURNAL OF IMMUNOLOGICAL METHODS, 2006, 311 (1-2) :178-188
[34]   Flexible SPR system able to switch between Kretschmann and SPRi [J].
Corso, Alain Jody ;
Zuccon, Sara ;
Zuppella, Paola ;
Pelizzo, Maria G. .
OPTICAL SENSORS 2015, 2015, 9506
[35]   Direct plasmonic detection of circulating RAS mutated DNA in colorectal cancer patients [J].
D'Agata, Roberta ;
Bellassai, Noemi ;
Allegretti, Matteo ;
Rozzi, Andrea ;
Korom, Sasa ;
Manicardi, Alex ;
Melucci, Elisa ;
Pescarmona, Edoardo ;
Corradini, Roberto ;
Giacomini, Patrizio ;
Spoto, Giuseppe .
BIOSENSORS & BIOELECTRONICS, 2020, 170
[36]  
Das S., 2022, Applied NanoMedicine, P360
[37]  
Dekker TJA, 2015, BREAST CANCER RES TR, V152, P247, DOI 10.1007/s10549-015-3444-x
[38]   Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach [J].
Dekker, Tim J. A. ;
Ter Borg, Susan ;
Hooijer, Gerrit K. J. ;
Meijer, Sybren L. ;
Wesseling, Jelle ;
Boers, James E. ;
Schuuring, Ed ;
Bart, Jos ;
van Gorp, Joost ;
Mesker, Wilma E. ;
Kroep, Judith R. ;
Smit, Vincent T. H. B. M. ;
van de Vijver, Marc J. .
BREAST CANCER RESEARCH, 2012, 14 (03)
[39]   Engineering Efficient Self-Assembled Plasmonic Nanostructures by Configuring Metallic Nanoparticle's Morphology [J].
Devaraj, Vasanthan ;
Lee, Jong-Min ;
Kim, Ye-Ji ;
Jeong, Hyuk ;
Oh, Jin-Woo .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
[40]   Distinguishable Plasmonic Nanoparticle and Gap Mode Properties in a Silver Nanoparticle on a Gold Film System Using Three-Dimensional FDTD Simulations [J].
Devaraj, Vasanthan ;
Lee, Jong-Min ;
Oh, Jin-Woo .
NANOMATERIALS, 2018, 8 (08)
12345678910